How much funding has AbelZeta Pharma raised?

AbelZeta Pharma has raised $120.0M in total funding, most recently a Venture Round.

When was AbelZeta Pharma founded?

AbelZeta Pharma was founded in 2009.

Where is AbelZeta Pharma headquartered?

AbelZeta Pharma is headquartered in Rockville, Maryland, United States.

What industry is AbelZeta Pharma in?

AbelZeta Pharma operates in Healthcare.

How many employees does AbelZeta Pharma have?

AbelZeta Pharma has 201-500 employees.

AbelZeta Pharma

Q: Who are AbelZeta Pharma's investors?

AbelZeta Pharma's investors include Alumni Ventures, EastBridge Investment Group, Sailing Capital.

Enabling immunity through innovative T cell-based therapeutics

Rockville, United States · Founded 2009 · $120.0M raised

Healthcare

Headquarters: Rockville, Maryland
Employees: 201–500
Founded: 2009
Business Model: B2B

Website: abelzeta.com
Total Funding: $120.0M
Last Round: $120.0M Venture Round
Rounds: 1

About

AbelZeta Pharma (formerly CBMG Holdings) is a global clinical-stage biopharmaceutical company focused on discovering, developing, and manufacturing cell-based therapeutics to address unmet medical needs. With centers of excellence in Rockville, Maryland and Shanghai, China, AbelZeta specializes in CAR-T cell therapy targeting hematologic malignancies, inflammatory and immunological diseases, and solid tumors. Founded in 2009, the company rebranded to AbelZeta Pharma in 2023 and has partnerships with Janssen Biotech (Johnson & Johnson) and AstraZeneca.

Summary

AbelZeta Pharma is a Healthcare company based in Rockville, United States, founded in 2009. It has raised $120.0M in total across 1 round. Investors include Alumni Ventures, EastBridge Investment Group and Sailing Capital.